Targeted DNA/RNA Sequencing Market: DNA-based Targeted Sequencing to be Highly Promising Segment
Targeted DNA/RNA Sequencing: Introduction
- Targeted sequencing is a rapid and cost-effective method to detect known and novel variants in selected sets of genes or genomic regions. Gene sequencing can be accomplished using several different DNA sequencing methods, depending on the scale.
- Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest. It offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=83683
Key Drivers of Global Targeted DNA/RNA Sequencing Market
- The global targeted DNA/RNA sequencing market is driven by continuous technological advancements and increase in availability of innovative & cost-effective sequencing platforms. Rise in usage of next generation sequencing methods such as exome sequencing and exome sequencing in research & development is projected to boost the growth of the global targeted DNA/RNA sequencing market during the forecast period.
- Major players focus on launch of new targeted DNA/RNA sequencing products. This is another major factor fueling the growth of the global market. For instance, in August 2020, Roche Molecular Systems, Inc. launched the new Exome and Custom KAPA Target Enrichment portfolio for translational and clinical applications in sequencing. In 2018, Twist Bioscience launched exome and custom target enrichment solutions for genomics and clinical researchers conducting next-generation sequencing.
Request for Analysis of COVID-19 Impact on Targeted DNA/RNA Sequencing Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=83683
DNA-based Targeted Sequencing to be Highly Promising Segment
- In terms of type, the global targeted DNA/RNA sequencing market can be bifurcated into DNA-based targeted sequencing and RNA-based targeted sequencing. DNA-based targeted sequencing is expected to be the leading segment during the forecast period.
- DNA-based targeted sequencing is the most common method used for sequencing, as it is cost-effective, requires less time compared to other methods, and availability of a range of products to facilitate DNA-seq
Drug Discovery Segment to Dominate Global Market
- Based on application, the global targeted DNA/RNA sequencing market can be categorized into drug discovery, human biomedical research, plant & animal sciences, and others. The drug discovery segment is likely to dominate the global market during the forecast period.
- EXOME sequencing, exome sequencing, and others are the most commonly used and preferred methods for drug discovery
Pre book Targeted DNA/RNA Sequencing Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=83683<ype=S
Academic & Research Institutes to be Most Promising Segment
- In terms of end-user, the global targeted DNA/RNA sequencing market can be divided into hospitals & clinics, academic & research institutes, and pharma & biotech companies. The academic & research institutes segment held significant share of the market in 2020. The segment is projected to witness strong growth during the forecast period.
- Increase in research & development activities in the past few years has led to rise in demand for targeted DNA/RNA sequencing in academic & research institutes. Moreover, scholarships offered for NGS-based PhD projects are anticipated to propel the segment.
North America to Dominate Global Targeted DNA/RNA Sequencing Market
- In terms of region, the global targeted DNA/RNA sequencing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- North America is projected to dominate the global market during the forecast period. However, the region is anticipated to lose market share by the end of 2027. Presence of large number of genome centers with installed sequencers and presence of major players drive the targeted DNA/RNA sequencing market in North America. Effective regulatory bodies to review the sequencing-based genetic tests and new technological advancements augment the market in the region.
- The targeted DNA/RNA sequencing market in Asia Pacific is expected to expand at a high CAGR during the forecast period
Read More Information: Top of Form
Read
https://www.transparencymarketresearch.com/targeted-dna-rna-sequencing-market.html
Key Players Operating in Global Targeted DNA/RNA Sequencing Market
The global targeted DNA/RNA sequencing market was highly fragmented in 2020. Key players operating in the global market are:
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd.
- Agilent Technologies
- Thermo Fisher Scientific, Inc.
- QIAGEN
- Perkin Elmer, Inc.
- Bio-Rad Laboratories, Inc.
- GATC Biotech AG
- DNASTAR, Inc.
- Integrated DNA Technologies, Inc.
- RainDance Technologies, Inc.
- Other prominent players
Browse More Trending Reports by Transparency Market Research:
Mucosal Atomization Devices Market:
Mucosal atomization devices are primarily used to deliver drugs through nasal mucosa for treating chronic diseases such as allergic rhinitis and sinusitis. The nasal route is being preferred increasingly by the medical sector as it allows rapid absorption of the therapeutics and offers superior efficiency. The popularity of mucosal atomization devices is on the rise as it provides a very solid alternative to the traditional needle-based injection drug delivery method. The shortcomings of the traditional method along with the fear among the patients have been imperative to such a rapid rise of the global mucosal atomization devices market.
Necrobiosis Lipoidica Diabeticorium Treatment Market:
Necrobiosis lipoidica diabeticorium is a very rare disease in diabetic patients. The condition is related to skin and results in reddish brown areas of the skin, primarily on the lower leg.It is a chronic granulomatous disease of the skin that affects lower legs, especially the shins. Yellowish brown, demarcated plaques are observed at lower extremities, with ulceration observed in around 30% of cases.The cause of necrosis lipoidica diabeticorium is not known. It is characterized by collagen degeneration, granuloma formation, and endothelial swelling. Type 1 diabetic patients are more prone to this disease than type 2 diabetic patients.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453